Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Johnandrose22on Feb 11, 2024 11:58am
218 Views
Post# 35874468

RE:RE:100 billion for chemo disrupter???

RE:RE:100 billion for chemo disrupter???In July, 2023, one of my closest friends was diagnosed with lung cancer. Annual checkups for the past 15 years were negative until, suddenly, Craig was told his diagnosis...stage 3 almost over night. Since then, my friend has undergone an intense protocol of treatment...chemotherapy and radiation. The price to pay for this treatment included a loss of 60 lbs, chronic fatigue, nausea, vomiting, depression, joint pain, loss of taste and a reduced desire to eat. Indeed, the treatment almost killed my friend as much as the cancer. Gratefully, Craig is still with us. Doctors consider his treatment a success because the tumors are still present, they just haven't grown or spread, yet. He will now begin immunotherapy to see if it could extend his life.

I realize that the company is currently focused on NMIBC and in the near future, hopefully, GBM. My reflection is simply to acknowledge how desperately those suffering with this God awful disease need an alternative treatment such as TLD 1433 to offer a ray of hope.

Pray for Craig.

John
<< Previous
Bullboard Posts
Next >>